Should You Hold Eloxx Pharmaceuticals Inc (ELOX) in Biotechnology Industry?

Monday, August 07, 2023 01:42 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Eloxx Pharmaceuticals Inc (ELOX) in Biotechnology Industry?

The 64 rating InvestorsObserver gives to Eloxx Pharmaceuticals Inc (ELOX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, ELOX’s 64 overall rating means the stock scores better than 64 percent of all stocks.

ELOX has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on ELOX!

See Full ELOX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Eloxx Pharmaceuticals Inc Stock Today?

Eloxx Pharmaceuticals Inc (ELOX) stock is down -4.82% while the S&P 500 is higher by 0.67% as of 1:42 PM on Monday, Aug 7. ELOX is down -$0.33 from the previous closing price of $6.78 on volume of 21,505 shares. Over the past year the S&P 500 is higher by 8.89% while ELOX is down -50.46%. ELOX lost -$14.16 per share the over the last 12 months. Click Here to get the full Stock Report for Eloxx Pharmaceuticals Inc stock.